ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 128 filers reported holding ENDOLOGIX INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $12,674,000 | +402.5% | 826,239 | +459.2% | 0.44% | +389.9% |
| Q1 2015 | $2,522,000 | -94.1% | 147,764 | -94.0% | 0.09% | -92.5% |
| Q4 2013 | $43,100,000 | +1.8% | 2,471,336 | -5.8% | 1.19% | -1.9% |
| Q3 2013 | $42,332,000 | +19.2% | 2,624,488 | -1.9% | 1.22% | +6.7% |
| Q2 2013 | $35,515,000 | – | 2,674,377 | – | 1.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $62,127,000 | 7.14% |
| Essex Woodlands Management, Inc. | 1,257,468 | $24,875,000 | 4.49% |
| First Light Asset Management, LLC | 304,602 | $4,673,000 | 2.20% |
| ArrowMark Colorado Holdings LLC | 3,464,775 | $53,150,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,449,897 | $37,581,000 | 1.25% |
| Iguana Healthcare Management, LLC | 200,000 | $3,068,000 | 0.97% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 82,316 | $1,262,000 | 0.71% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,651,798 | $25,339,000 | 0.64% |
| PERKINS CAPITAL MANAGEMENT INC | 34,200 | $525,000 | 0.46% |
| CADIAN CAPITAL MANAGEMENT, LP | 967,443 | $14,841,000 | 0.44% |